Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Adenosine A2A receptors and depression.

Malika El Yacoubi¹, Jean Costentin, Jean-Marie Vaugeois

¹UMR 6036 CNRS, IFRMP 23, U.F.R. de Médecine & Pharmacie, Rouen, France.

|December 10, 2003

Summary

Selective adenosine A2A receptor antagonists show promise as novel antidepressants by reversing behavioral despair in animal models. This suggests A2A receptor blockade is a potential therapeutic target for depression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction: Karoui et al. Nitrogen Dioxide Inhalation Exposures Induce Cardiac Mitochondrial Reactive Oxygen Species Production, Impair Mitochondrial Function and Promote Coronary Endothelial Dysfunction. <i>Int. J. Environ. Res. Public Health</i> 2020, <i>17</i>, 5526.

International journal of environmental research and public health·2025

Same author

[Cannabis also has epigenetic effects].

La Revue du praticien·2024

Same author

Two polygenic mouse models of major depressive disorders identify TMEM161B as a potential biomarker of disease in humans.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2024

Same author

Ultrafine Particles Issued from Gasoline-Fuels and Biofuel Surrogates Combustion: A Comparative Study of the Physicochemical and <i>In Vitro</i> Toxicological Effects.

Toxics·2023

Same author

Desloratadine, an FDA-approved cationic amphiphilic drug, inhibits SARS-CoV-2 infection in cell culture and primary human nasal epithelial cells by blocking viral entry.

Scientific reports·2022

Same author

Development of a standardized in vitro approach to evaluate microphysical, chemical, and toxicological properties of combustion-derived fine and ultrafine particles.

Journal of environmental sciences (China)·2021

Area of Science:

Neuroscience
Pharmacology

Background:

Adenosine and its analogues can induce "behavioral despair" in animal models relevant to depression.
Selective adenosine A2A receptor antagonists have demonstrated efficacy in reversing these despair behaviors.

Purpose of the Study:

To investigate the antidepressant-like effects of selective adenosine A2A receptor antagonists.
To explore the potential interaction between A2A antagonists and dopaminergic transmission in mediating antidepressant effects.

Main Methods:

Utilized tail suspension and forced swim tests in animal models to assess antidepressant activity.
Administered selective A2A antagonists (SCH 58261, ZM241385, KW6002) and caffeine.
Investigated the role of dopaminergic transmission using the dopamine D2 receptor antagonist haloperidol.

Related Experiment Videos

Main Results:

Selective adenosine A2A receptor antagonists effectively reversed behavioral despair in tail suspension and forced swim tests.
The antidepressant-like effect of a selective A2A antagonist (SCH 58261) was blocked by haloperidol, suggesting a link to dopaminergic transmission in the frontal cortex.
Caffeine, a nonselective antagonist, showed some effects but lacked a clear-cut antidepressant profile and differed in its interaction with haloperidol.

Conclusions:

Selective blockade of the adenosine A2A receptor represents a promising therapeutic target for developing novel antidepressant agents.
The antidepressant-like effects of A2A antagonists appear to be mediated, at least in part, through interactions with the dopaminergic system.